Skip to the page

Data / Drug companies / Alkylating Drug

Alkylating Drug drugs: 19 drugs from 47 companies in the FDA NDC directory

Alkylating Drug is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 187 products in this class from 47 companies, covering 19 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 31, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 47Companies
  • 187Products
  • 19Drugs by generic name

Drugs in the Alkylating Drug class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Mitomycin3314
Carmustine113
Temozolomide7312
Bendamustine hydrochloride1510
Thiotepa178
Busulfan98
Ifosfamide115
Lomustine124
Dacarbazine43
Trabectedin22
Bendamustine hcl21
Chlorambucil11
Ifosfamide for injection11
Lurbinectedin11
Mechlorethamine hydrochloride11
Melphalan11
Melphalan hcl11
Procarbazine hydrochloride11
Streptozocin11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Accord Healthcare Inc.12capsule; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 7, 2022
Meitheal Pharmaceuticals Inc.12injection, powder, lyophilized, for solution; injection, solutionGeneric drugs (ANDA)April 22, 2024
Hikma Pharmaceuticals USA Inc.10injection, powder, lyophilized, for solution; injectionGeneric drugs (ANDA)September 29, 2023
Bryant Ranch Prepack7capsule; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)March 11, 2022
Merck Sharp & Dohme LLC7capsule; injection, powder, lyophilized, for solutionNew drug applications (NDA)February 27, 2009
Amneal Pharmaceuticals LLC6capsuleGeneric drugs (ANDA)April 3, 2015
Ascend Laboratories, LLC6capsuleGeneric drugs (ANDA)April 28, 2017
Camber Pharmaceuticals, Inc.6capsuleGeneric drugs (ANDA)August 23, 2024
CivicaScript LLC6capsuleGeneric drugs (ANDA)August 10, 2026
Devatis, Inc.6capsuleGeneric drugs (ANDA)April 28, 2017
Eugia US LLC6injection, powder, lyophilized, for solution; injection, solutionGeneric drugs (ANDA)June 25, 2024
Nivagen Pharmaceuticals, Inc.6capsuleGeneric drugs (ANDA)December 7, 2021
Opko Pharmaceuticals, LLC6capsuleGeneric drugs (ANDA)October 31, 2026
Rising Pharma Holdings, Inc.6capsuleGeneric drugs (ANDA)October 4, 2022
Sun Pharmaceutical Industries, Inc.6capsuleGeneric drugs (ANDA)February 13, 2014
Amneal Pharmaceuticals LLC5injection, powder, for solution; injection, powder, lyophilized, for solutionNew drug applications (NDA)April 18, 2025
Azurity Pharmaceuticals, Inc.5capsule, gelatin coated; injectionNew drug applications (NDA)October 24, 2025
Baxter Healthcare Company5injection, powder, for solution; injectionNew drug applications (NDA)December 15, 2022
Gland Pharma Limited5injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 22, 2022
Sagent Pharmaceuticals5injection, powder, lyophilized, for solution; injection, solution, concentrateGeneric drugs (ANDA)June 15, 2023
Archis Pharma LLC4injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 25, 2022
BluePoint Laboratories4injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 11, 2024
Fresenius Kabi USA, LLC4injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 15, 2023
Apotex Corp.3injection, solution; injection, solution, concentrateNew drug applications (NDA)June 30, 2026
Carnegie Pharmaceuticals LLC3capsuleGeneric drugs (ANDA)November 10, 2025
Cephalon, LLC3injection, powder, lyophilized, for solution; injection, solutionNew drug applications (NDA)December 8, 2015
Fresenius Kabi USA, LLC3injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 28, 2003
NextSource Biotechnology, LLC3capsule, gelatin coatedNew drug applications (NDA)August 18, 2014
Wilshire Pharmaceuticals, Inc.3capsule, gelatin coatedNew drug applications (NDA)April 15, 2026
Accord BioPharma Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 25, 2017
Avyxa Pharma, LLC2injection, solution; injectionNew drug applications (NDA)September 25, 2026
Baxter Healthcare Corporation2injection, powder, for solutionNew drug applications (NDA)December 30, 1988
Dr. Reddy's Laboratories Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2022
Novadoz Pharmaceuticals LLC2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)February 1, 2020
Waylis Therapeutics LLC2tablet, film coatedNew drug applications (NDA)May 15, 2023
Acrotech Biopharma Inc1injection, powder, lyophilized, for solutionNew drug applications (NDA)March 31, 2016
Bryant Ranch Prepack1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)March 11, 2022
Eagle Pharmaceuticals, Inc.1injectionNew drug applications (NDA)June 3, 2019
Esteve Pharmaceuticals, S.A.1powder, for solutionUnapproved drugs for a shortageJuly 10, 2025
Helsinn Therapeutics (U.S.), Inc.1gelNew drug applications (NDA)November 8, 2018
Hospira, Inc.1injection, solutionGeneric drugs (ANDA)February 28, 2019
Janssen Products, LP1injection, powder, lyophilized, for solutionNew drug applications (NDA)October 23, 2015
Jazz Pharmaceuticals, Inc.1injection, powder, lyophilized, for solutionNew drug applications (NDA)June 15, 2020
Leadiant Biosciences, Inc.1capsuleNew drug applications (NDA)December 27, 1985
Pharmascience Inc.1injectionGeneric drugs (ANDA)May 19, 2017
Slayback Pharma LLC1injectionNew drug applications (NDA)December 7, 2022
SteriMax Inc.1powder, for solutionUnapproved drugs for a shortageSeptember 4, 2026

Dosage forms

Dosage formProductsShare
Capsule7640.6%
Injection, powder, lyophilized, for solution6132.6%
Injection, powder, for solution137%
Injection, solution105.3%
Injection105.3%
Capsule, gelatin coated94.8%
Tablet, film coated21.1%
Injection, solution, concentrate21.1%
Powder, for solution21.1%
Wafer10.5%
Gel10.5%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.